| |
| |
|
| Insider
Information: |
Kewalramani Reshma |
| Relationship: |
Director |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
217,246 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$54,328,246 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
217,246 |
|
|
| Total
Value |
$54,328,246 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 23.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
CEO & President, Direc... |
2024-02-23 |
136,507 |
2018-10-08 |
0 |
Premium* |
|
|
Ginkgo Bioworks Holdings, Inc |
DNA |
Director |
2022-09-30 |
80,739 |
2022-06-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2024-02-23 |
4 |
D |
$431.79 |
$4,052,781 |
D/D |
(9,386) |
136,507 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2024-02-20 |
4 |
D |
$420.58 |
$2,952,051 |
D/D |
(7,019) |
145,893 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2024-02-16 |
4 |
D |
$424.01 |
$3,968,310 |
D/D |
(9,359) |
152,912 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2024-02-09 |
4 |
D |
$422.74 |
$3,489,719 |
D/D |
(8,255) |
162,271 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
20,327 |
170,526 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
41,488 |
150,199 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2023-12-15 |
4 |
OE |
$155.57 |
$3,115,593 |
D/D |
17,135 |
125,846 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2023-12-15 |
4 |
AS |
$407.00 |
$6,973,945 |
D/D |
(17,135) |
108,711 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2023-12-13 |
4 |
AS |
$397.00 |
$2,023,906 |
D/D |
(5,098) |
108,711 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2023-11-13 |
4 |
AS |
$377.00 |
$1,921,569 |
D/D |
(5,097) |
113,809 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2023-07-17 |
4 |
AS |
$355.00 |
$2,778,940 |
D/D |
(7,828) |
118,906 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2023-04-27 |
4 |
AS |
$338.69 |
$1,124,726 |
D/D |
(3,317) |
126,652 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2023-02-24 |
4 |
D |
$289.12 |
$2,713,680 |
D/D |
(9,386) |
129,969 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2023-02-17 |
4 |
D |
$292.85 |
$2,740,783 |
D/D |
(9,359) |
139,355 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2023-02-13 |
4 |
D |
$298.26 |
$1,786,577 |
D/D |
(5,990) |
148,714 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2023-02-10 |
4 |
D |
$294.33 |
$992,481 |
D/D |
(3,372) |
154,704 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
68,478 |
158,076 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2023-01-25 |
4 |
AS |
$315.05 |
$3,150,500 |
D/D |
(10,000) |
89,598 |
0 |
% |
|
| DNA |
Ginkgo Bioworks Holdings,... |
Director |
– • – |
2022-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,818 |
80,739 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2022-08-15 |
4 |
AS |
$305.06 |
$3,565,846 |
D/D |
(11,689) |
99,598 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2022-06-24 |
4 |
AS |
$291.30 |
$3,405,006 |
D/D |
(11,689) |
111,153 |
0 |
% |
|
| DNA |
Ginkgo Bioworks Holdings,... |
Director |
– • – |
2022-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
70,921 |
70,921 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2022-02-24 |
4 |
D |
$227.86 |
$1,651,074 |
D/D |
(7,246) |
122,842 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2022-02-17 |
4 |
D |
$232.51 |
$1,995,866 |
D/D |
(8,584) |
130,088 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
• • – |
2022-02-10 |
4 |
D |
$237.74 |
$720,590 |
D/D |
(3,031) |
138,672 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
